A5102993513- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Innovations in Medical Education
- Neuroblastoma Research and Treatments
- Vascular Tumors and Angiosarcomas
- Metastasis and carcinoma case studies
- Diversity and Career in Medicine
- Surgical Simulation and Training
- Cardiac tumors and thrombi
- Gastrointestinal Tumor Research and Treatment
- Pancreatic and Hepatic Oncology Research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hospital Admissions and Outcomes
- Bone Tumor Diagnosis and Treatments
- Virus-based gene therapy research
- Cardiac, Anesthesia and Surgical Outcomes
- Helicobacter pylori-related gastroenterology studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Soft tissue tumor case studies
- Neurofibromatosis and Schwannoma Cases
- Herpesvirus Infections and Treatments
- Healthcare professionals’ stress and burnout
- Lung Cancer Diagnosis and Treatment
- Medical Education and Admissions
Massachusetts General Hospital
2016-2025
Harvard University
2014-2024
University of Hawaiʻi at Mānoa
2024
Phoenix Children's Hospital
2023
Harvard University Press
2002-2022
University of Colorado Denver
2022
Memorial Sloan Kettering Cancer Center
2022
Society of Surgical Oncology
2021
American College of Surgeons
2014-2020
Université de Rouen Normandie
2019
In Brief Objective: We sought to examine the effect of body mass index (BMI) on 30-day morbidity and mortality in a large cohort patients undergoing nonbariatric general surgery. Summary Background Data: Obesity has long been considered risk factor for poor outcomes from variety surgical procedures, yet recent studies critically chronically ill suggest that overweight obese may paradoxically have better than “normal” weight patients. Methods: A prospective, multi-institutional, risk-adjusted...
To evaluate the efficacy and safety of high-dose, hypofractionated proton beam therapy for hepatocellular carcinoma (HCC) intrahepatic cholangiocarcinoma (ICC).In this single-arm, phase II, multi-institutional study, 92 patients with biopsy-confirmed HCC or ICC, determined to be unresectable by multidisciplinary review, a Child-Turcotte-Pugh score (CTP) A B, ECOG performance status 0 2, no extrahepatic disease, prior radiation received 15 fractions maximum total dose 67.5 Gy equivalent....
Carcinoid tumors of the appendix are rare, and as such there few data guiding their optimal treatment.The analysis included all patients with malignant, typical carcinoid tumor for whom complete were available in Surveillance, Epidemiology, End Results database between 1988 2003. Clinicopathologic factors predicting lymph node (LN) involvement survival determined.LN metastases present 44 89 (49%), including 4 27 (15%) ≤ 1.0 cm, 16 34 (47%) > cm but 2.0 24 28 (86%) >2.0 cm. Increasing size...
Learning Objectives Describe the frequency of CTNNB1 mutations in sporadic desmoid tumors. Summarize findings regarding mutation status and disease outcome.
We evaluated the efficacy and safety of risk-adapted, proton-based stereotactic body radiation therapy (SBRT) for liver metastases from solid tumors.This single-arm phase II single institutional study (NCT01239381) included patients with limited extrahepatic disease, 800 mL or greater uninvolved liver, no cirrhosis Child-Pugh A, who had received SBRT to one four tumors. Treatment comprised 30 50 Gray equivalent (GyE) in five fractions based on effective volume irradiated. Sample size was...
Abstract Purpose: The role of surgery for first relapse locally recurrent retroperitoneal sarcoma (RPS-LR1) is uncertain. We report outcomes the largest RPS-LR1 series and propose a new prognostic nomogram. Experimental Design: Patients with consecutive without distant metastases who underwent resection at 22 centers (2002–2011) were included. Endpoints disease-free overall survival (DFS, OS) crude-cumulative-incidence (CCI) local/distant recurrence from second surgery. Nomograms predicting...
Patient-generated health data captured from smartphone sensors have the potential to better quantify physical outcomes of surgery. The ability these discriminate between postoperative trends in activity remains unknown.To assess whether accelerometer can be used describe recovery among patients undergoing cancer operations.This prospective observational cohort study was conducted July 2017 April 2019 a single academic tertiary care hospital United States. Preoperatively, adults (age ≥18...